Leerink Partners Downgrades Aclaris Therapeutis (ACRS) to Market Perform
Tweet Send to a Friend
(Updated - November 14, 2023 4:31 AM EST)
Leerink Partners analyst Thomas J. Smith downgraded Aclaris Therapeutis (NASDAQ: ACRS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Leerink Partners analyst Thomas J. Smith downgraded Aclaris Therapeutis (NASDAQ: ACRS) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
